Sign In
Buy MRVI
$6.07
-0.160 (-2.57%)
At Close: Aug 10, 2026
Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q1 Earnings and Revenue Estimates
06:55pm, Thursday, 07'th May 2026
Maravai LifeSciences Holdings, Inc. (MRVI) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.05 per share. This compares to a loss of $0.08 per
Maravai LifeSciences Reports First Quarter 2026 Financial Results
04:01pm, Thursday, 07'th May 2026
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported
All You Need to Know About Maravai LifeSciences (MRVI) Rating Upgrade to Buy
01:01pm, Wednesday, 06'th May 2026
Maravai LifeSciences (MRVI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Baxter International (BAX) Tops Q1 Earnings and Revenue Estimates
09:30am, Thursday, 30'th Apr 2026
Baxter International (BAX) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.55 per share a year ago.
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Average Rating of “Hold” from Brokerages
02:38am, Monday, 06'th Apr 2026
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI - Get Free Report) has been given a consensus recommendation of "Hold" by the five analysts that are presently covering the firm, Marketbeat.com repor
Investors Purchase Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI)
01:09am, Thursday, 02'nd Apr 2026
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI - Get Free Report) was the target of some unusual options trading activity on Wednesday. Traders bought 1,002 put options on the stock. This represent
Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2025 Earnings Call Transcript
05:08pm, Thursday, 26'th Feb 2026
Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2025 Earnings Call Transcript
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates
08:25pm, Wednesday, 25'th Feb 2026
Maravai LifeSciences Holdings, Inc. (MRVI) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.06 per share a year a
Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results
04:01pm, Wednesday, 25'th Feb 2026
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported
Maravai LifeSciences (MRVI) to Release Quarterly Earnings on Wednesday
05:48am, Monday, 23'rd Feb 2026
Maravai LifeSciences (NASDAQ: MRVI - Get Free Report) will likely be issuing its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect the company to announce earnings o
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026
05:05pm, Monday, 09'th Feb 2026
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fo
Maravai LifeSciences Target of Unusually High Options Trading (NASDAQ:MRVI)
01:42am, Thursday, 05'th Feb 2026
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI - Get Free Report) was the target of some unusual options trading on Wednesday. Traders acquired 1,002 put options on the company. This represents an
General American Investors Co. Inc. Takes Position in Maravai LifeSciences Holdings, Inc. $MRVI
04:50am, Tuesday, 27'th Jan 2026
General American Investors Co. Inc. acquired a new stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) during the third quarter, according to the company in its most recent filing wi
Maravai LifeSciences (NASDAQ:MRVI) & Capricor Therapeutics (NASDAQ:CAPR) Critical Review
01:10am, Monday, 12'th Jan 2026
Capricor Therapeutics (NASDAQ: CAPR - Get Free Report) and Maravai LifeSciences (NASDAQ: MRVI - Get Free Report) are both small-cap medical companies, but which is the better business? We will contras
Investors Purchase High Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI)
02:12am, Thursday, 27'th Nov 2025
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI - Get Free Report) was the target of unusually large options trading on Wednesday. Stock traders bought 1,002 put options on the stock. This represent
